Related Experiment Video

Updated: Apr 22, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.1K

Drosophila casein kinase 2 (CK2) promotes warts protein to suppress Yorkie protein activity for growth control

Lianxin Hu1, Hongling Huang1, Jinhui Li1

  • 1From the State Key Laboratory of Cell Biology and.

The Journal of Biological Chemistry
|October 17, 2014
PubMed

Insights

Drosophila CK2 enhances Hippo pathway activity to inhibit Yki, controlling tissue growth. It also acts as a cell death inhibitor, revealing a dual role in growth regulation.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cell Signaling

Background:

  • The Hippo signaling pathway, comprising Hpo and Wts kinases, regulates tissue growth by phosphorylating and inhibiting Yki.
  • CK2 is a ubiquitous protein kinase implicated in diverse cellular processes and signaling pathways.

Purpose of the Study:

  • To investigate the role of Drosophila CK2 in the Hippo signaling pathway and its impact on tissue growth.
  • To elucidate the mechanism by which CK2 influences Wts and Yki activity.
  • To determine if CK2 has a role in cell survival and its implications for tissue development.

Main Methods:

  • Genetic manipulation in Drosophila, including overexpression and knockdown of CK2.
  • Analysis of Hippo pathway components (Wts, Yki) and target gene expression (Ex).
  • Assessment of tissue overgrowth phenotypes and cell death markers (caspase 3).

Main Results:

  • Drosophila CK2 promotes Wts activity, leading to Yki inhibition, independently of Hpo.
  • CK2 overexpression suppresses hpo mutant phenotypes, while CK2 knockdown enhances Hippo pathway activity.
  • CK2 is crucial for tissue growth, acting as a cell death inhibitor; its knockdown induces growth defects and caspase 3 signaling.

Conclusions:

  • Drosophila CK2 plays a dual role in tissue growth, primarily promoting cell survival as a cell death inhibitor.
  • CK2 modulates Hippo signaling by enhancing Wts activity, independent of Hpo, suggesting a novel regulatory mechanism.
  • While promoting survival, CK2's influence on the Hippo pathway suggests it may also act as a potential growth inhibitor under certain contexts.
Keywords:
Cell SignalingDrosophilaHippo PathwayPhosphorylationTumor PromoterTumor Suppressor Gene

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.8K
Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae10:57

Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae

Published on: February 16, 2015

8.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.3K